ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Cardiovascular disease is the leading cause of death in the United States, claiming an estimated 1 million lives, and incurring a cost of $400 billion per year. Much of cardiovascular disease can be ...

Abbott already churns out a variety of catheters, stents, imaging systems and other technologies used to remove plaque buildups from blood vessels and keep the blood flowing through the newly cleaned ...

Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...

Cellular biomechanics of neural and vascular injury, mechanotransduction in the cardiovascular system, mechanical control of growth and development for wound healing and tissue engineering Engineering ...

For decades, cardiology has been among the most advanced fields in medicine. We have strong evidence, effective medications and clear guidelines for preventing heart attacks and strokes. And yet, ...

“During Q4, we achieved strong sequential growth across all business segments with our U.S. peripheral and coronary atherectomy franchises growing 9% and 16% over prior quarter, respectively.